ARTICLE | Clinical News
Cenderitide regulatory update
April 4, 2011 7:00 AM UTC
FDA granted Fast Track designation for Nile's cenderitide to treat patients with acute decompensated heart failure (ADHF) in the post-acute period. Nile plans to start a Phase II trial of the selectiv...